LEO Pharma closes Bayer’s prescription dermatology unit deal in US
LEO Pharma has completed the acquisition of Bayer’s prescription dermatology portfolio in the US. The deal is expected to also…
Bayer
-
-
Bayer’s new haemophilia A drug obtains FDA approval
Bayer has received approval from the US Food and Drug Administration (FDA) for its new haemophilia A drug Jivi (BAY94-9027)…
-
LEO Pharma to acquire Bayer’s prescription dermatology portfolio
Denmark-based LEO Pharma has signed a definitive agreement to acquire Bayer’s global prescription dermatology unit in a bid to expand…
-
Bayer and Broad Institute expand heart therapy collaboration
The Broad Institute of MIT and Harvard have expanded its strategic partnership with Bayer to launch the new Precision Cardiology…
